Synergistic effect of α-dihydroergocryptine and L-dopa or dopamine on dopaminergic neurons in primary culture

Journal of Neural Transmission

Volumn 113, Issue 9, 2006, Pages 1107-1118

  Gille, G ^a   Radad, K ^b   Reichmann, H ^a   Rausch, W D ^b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

Dihydroergocryptine; Dopamine; Dopaminergic neurons; L dopa; Synergism

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1 METHYL 4 PHENYLPYRIDINIUM IODIDE; CARBIDOPA; DIHYDROERGOCRYPTINE; DOPAMINE; DOPAMINE RECEPTOR; LEVODOPA; SULPIRIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; DRUG POTENTIATION; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; CARBIDOPA; CELL COUNT; CELLS, CULTURED; DIHYDROERGOCRYPTINE; DOPAMINE; DOPAMINE AGENTS; DOPAMINE ANTAGONISTS; DRUG SYNERGISM; FEMALE; LACTIC ACID; LEVODOPA; MICE; NEUROGLIA; NEURONS; PREGNANCY; SULPIRIDE; TYROSINE 3-MONOOXYGENASE;

EID: 33747882349     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-005-0369-2     Document Type: Article

References (72)

1. A Albanese C Colosimo 2003 Dihydroergocriptine in Parkinson's disease: clinical efficacy and comparison with other dopamine agonists Acta Neurol Scand 107 349 355
2. T Alexander CE Sortwell CD Sladek RH Roth K Steece-Collier 1997 Comparison of neurotoxicity following repeated administration of L-dopa, D-dopa and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from Fisher 344 and Sprague-Dawley donors Cell Transplant 6 309 315
3. M Asanuma I Miyazaki N Ogawa 2003 Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease Neurotox Res 5 165 176
4. A Bal T Bachelot M Savasta M Manier JM Verna AL Benabid C Feuerstein 1994 Evidence for dopamine D2 receptor mRNA expression by striatal astrocytes in culture: in situ hybridization and polymerase chain reaction studies Brain Res Mol Brain Res 23 204 212
5. AN Basma EJ Morris WJ Nicklas HM Geller 1995 L-dopa cytotoxicity to PC12 cells in culture is via its autoxidation J Neurochem 64 825 832
6. M Battino GP Littarru A Gorini RF Villa 1996 Coenzyme Q, peroxidation and cytochrome oxidase features after parkinson's-like disease by MPTP toxicity in intra-synaptic and non-synaptic mitochondria from Macaca fascicularis cerebral cortex and hippocampus: action of dihydroergocriptine Neurochem Res 21 1505 1514
7. B Bergamasco L Frattola A Muratorio F Piccoli F Mailland L Parnetti 2000 Alpha-dihydroergocryptine in the treatment of de novo parkinsonian patients: results of a multicentre, randomized, double-blind, placebo-controlled study Acta Neurol Scand 101 372 380
8. G Bernocchi G Gerzeli E Scherini C Vignola 1993 Neuroprotective effects of alpha-dihydroergocryptine against damages in the substantia nigra caused by severe treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Acta Neuropathol (Berl) 85 404 413
9. A Bindoli MP Rigobello DJ Deeble 1992 Biochemical and toxicological properties of the oxidation products of catecholamines Free Radic Biol Med 13 391 405
10. H Blessing M Bareiss H Zettlmeisl J Schwarz A Storch 2003 Catechol-O-methyltransferase inhibition protects against 3,4- dihydroxyphenylalanine (DOPA) toxicity in primary mesencephalic cultures: new insights into levodopa toxicity Neurochem Int 42 139 151
11. DS Cassarino CP Fall TS Smith JP Bennett Jr 1998 Pramipexole reduces reactive oxygen species production in vivo and in vitro and inhibits the mitochondrial permeability transition produced by the parkinsonian neurotoxin methylpyridinium ion J Neurochem 71 295 301
12. G Coppi 1995 Neuroprotective activity of alpha-dihydroergocryptine in animal models J Neural Transm [Suppl] 45 307 318
13. J Engele MC Bohn 1991 The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia J Neurosci 11 3070 3078
14. J Engele D Schubert MC Bohn 1991 Conditioned media derived from glial cell lines promote survival and differentiation of dopaminergic neurons in vitro: role of mesencephalic glia J Neurosci Res 30 359 371
15. S Fahn D Oakes I Shoulson K Kieburtz A Rudolph A Lang CW Olanow C Tanner K Marek 2004 Levodopa and the progression of Parkinson's disease N Engl J Med 351 2498 2508
16. S Fahn S Przedborski 2000 Parkinsonism LP Rowland Merritt's neurology Lippincott Williams & Wilkins New York 679 693
17. A Favit MA Sortino G Aleppo U Scapagnini PL Canonico 1995 The inhibition of peroxide formation as a possible substrate for the neuroprotective action of dihydroergocryptine J Neural Transm [Suppl] 45 297 305
18. P Foley M Gerlach KL Double P Riederer 2004 Dopamine receptor agonists in the therapy of Parkinson's disease J Neural Transm 111 1375 1446
19. M Gerlach K Double T Arzberger F Leblhuber T Tatschner P Riederer 2003 Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum J Neural Transm 110 1119 1127
20. G Gille WD Rausch ST Hung R Moldzio B Janetzky HP Hundemer T Kolter H Reichmann 2002a Pergolide protects dopaminergic neurons in primary culture under stress conditions J Neural Transm 109 633 643
21. G Gille WD Rausch ST Hung R Moldzio A Ngyuen B Janetzky A Engfer H Reichmann 2002b Protection of dopaminergic neurons in primary culture by lisuride J Neural Transm 109 157 169
22. MR Gluck GD Zeevalk 2004 Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine-associated diseases J Neurochem 91 788 795
23. C Gomez-Santos I Ferrer AF Santidrian M Barrachina J Gil S Ambrosio 2003 Dopamine induces autophagic cell death and alpha-synuclein increase in human neuroblastoma SH-SY5Y cells J Neurosci Res 73 341 350
24. DG Graham 1978 Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones Mol Pharmacol 14 633 643
25. E Grunblatt S Mandel G Maor MB Youdim 2001 Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss J Neurochem 77 146 156
26. M Gu M Irvani JM Cooper D King P Jenner AH Schapira 2004 Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms J Neurochem 91 1075 1081
27. SK Han C Mytilineou G Cohen 1996 L-DOPA up-regulates glutathione and protects mesencephalic cultures against oxidative stress J Neurochem 66 501 510
28. M Iida I Miyazaki K Tanaka H Kabuto E Iwata-Ichikawa N Ogawa 1999 Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist Brain Res 838 51 59
29. JN Joyce C Woolsey H Ryoo S Borwege D Hagner 2004 Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor BMC Biol 2 22
30. S Junghanns T Glockler H Reichmann 2004 Switching and combining of dopamine agonists J Neurol 251 VI/19 VI/23
31. Y Kitamura T Kosaka JI Kakimura Y Matsuoka Y Kohno Y Nomura T Taniguchi 1998 Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells Mol Pharmacol 54 1046 1054
32. I Lamensdorf G Eisenhofer J Harvey-White Y Hayakawa K Kirk IJ Kopin 2000 Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4-dihydroxyphenylacetaldehyde J Neurosci Res 60 552 558
33. WD Le J Jankovic 2001 Are dopamine receptor agonists neuroprotective in Parkinson's disease? Drugs Aging 18 389 396
34. ZD Ling SC Pieri PM Carvey 1996 Comparison of the neurotoxicity of dihydroxyphenylalanine stereoisomers in cultured dopamine neurons Clin Neuropharmacol 19 360 365
35. ZD Ling HC Robie CW Tong PM Carvey 1999 Both the antioxidant and D3 agonist actions of pramipexole mediate its neuroprotective actions in mesencephalic cultures J Pharmacol Exp Ther 289 202 210
36. P Maher D Schubert 2000 Signaling by reactive oxygen species in the nervous system Cell Mol Life Sci 57 1287 1305
37. E Mailland P Magnani B Ottillinger 2004 Alpha-dihydroergocriptine in the long-term therapy of Parkinson's disease Arzneimittelforschung 54 647 654
38. MA Mena MJ Casarejos A Carazo CL Paino DY Garcia 1996 Glia conditioned medium protects fetal rat midbrain neurones in culture from L-DOPA toxicity Neuroreport 7 441 445
39. MA Mena MJ Casarejos A Carazo CL Paino DY Garcia 1997a Glia protect fetal midbrain dopamine neurons in culture from L-DOPA toxicity through multiple mechanisms J Neural Transm 104 317 328
40. MA Mena V Davila J Bogaluvsky D Sulzer 1998 A synergistic neurotrophic response to l-dihydroxyphenylalanine and nerve growth factor Mol Pharmacol 54 678 686
41. MA Mena V Davila D Sulzer 1997b Neurotrophic effects of L-DOPA in postnatal midbrain dopamine neuron/cortical astrocyte cocultures J Neurochem 69 1398 1408
42. MA Mena B Pardo CL Paino JG De Yebenes 1993 Levodopa toxicity in foetal rat midbrain neurones in culture: modulation by ascorbic acid Neuroreport 4 438 440
43. I Miyazaki M Asanuma FJ Diaz-Corrales K Miyoshi N Ogawa 2004 Direct evidence for expression of dopamine receptors in astrocytes from basal ganglia Brain Res 1029 120 123
44. D Muralikrishnan KP Mohanakumar 1998 Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice FASEB J 12 905 912
45. C Mytilineou SK Han G Cohen 1993 Toxic and protective effects of L-dopa on mesencephalic cell cultures J Neurochem 61 1470 1478
46. EK O'Malley BA Sieber IB Black CF Dreyfus 1992 Mesencephalic type I astrocytes mediate the survival of substantia nigra dopaminergic neurons in culture Brain Res 582 65 70
47. N Ogawa K Tanaka M Asanuma M Kawai T Masumizu M Kohno A Mori 1994 Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro Brain Res 657 207 213
48. CW Olanow 1992 An introduction to the free radical hypothesis in Parkinson's disease Ann Neurol 32 [Suppl] S2 S9
49. CW Olanow Y Agid Y Mizuno A Albanese U Bonucelli P Damier J De Yebenes O Gershanik M Guttman F Grandas M Hallett O Hornykiewicz P Jenner R Katzenschlager WJ Langston P LeWitt E Melamed MA Mena PP Michel C Mytilineou JA Obeso W Poewe N Quinn R Raisman-Vozari AH Rajput O Rascol C Sampaio F Stocchi 2004 Levodopa in the treatment of Parkinson's disease: current controversies Mov Disord 19 997 1005
50. B Pardo MA Mena MJ Casarejos CL Paino JG De Yebenes 1995 Toxic effects of L-DOPA on mesencephalic cell cultures: protection with antioxidants Brain Res 682 133 143
51. Parkinson Study Group 2002 Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression JAMA 287 1653 1661
52. R Pedrosa P Soares-da-Silva 2002 Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by L-3,4-dihydroxyphenylalanine (L-DOPA) and dopamine Br J Pharmacol 137 1305 1313
53. EW Pelton HK Kimelberg SV Shipherd RS Bourke 1981 Dopamine and norepinephrine uptake and metabolism by astroglial cells in culture Life Sci 28 1655 1663
54. Z Pirtosek D Flisar 2004 Neuroprotection and dopamine agonists Adv Exp Med Biol 541 55 74
55. S Przedborski V Jackson-Lewis U Muthane H Jiang M Ferreira AB Naini S Fahn 1993 Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity Ann Neurol 34 715 723
56. H Reichmann B Herting A Miller U Sommer 2003 Switching and combining dopamine agonists J Neural Transm 110 1393 1400
57. B Reuss K Unsicker 2000 Survival and differentiation of dopaminergic mesencephalic neurons are promoted by dopamine-mediated induction of FGF-2 in striatal astroglial cells Mol Cell Neurosci 16 781 792
58. E Rodriguez-Martin S Canals MJ Casarejos S de Bernardo A Handler MA Mena 2001 L-DOPA and glia-conditioned medium have additive effects on tyrosine hydroxylase expression in human catecholamine-rich neuroblastoma NB69 cells J Neurochem 78 535 545
59. B Sampaio-Maia MP Serrao P Soares-da-Silva 2001 Regulatory pathways and uptake of L-DOPA by capillary cerebral endothelial cells, astrocytes, and neuronal cells Am J Physiol Cell Physiol 280 C333 C342
60. H Sauer M Wartenberg J Hescheler 2001 Reactive oxygen species as intracellular messengers during cell growth and differentiation Cell Physiol Biochem 11 173 186
61. AH Schapira 2003 Neuroprotection in PD-A role for dopamine agonists? Neurology 61 S34 S42
62. S Schinelli M Paolillo M Quartieri G Santagostino 1993 Dopamine synthesis, uptake and metabolism in embryonic rat mesencephalic cultures Pharmacol Res 28 265 276
63. P Seeman HH Van Tol 1994 Dopamine receptor pharmacology Trends Pharmacol Sci 15 264 270
64. JP Spencer P Jenner SE Daniel AJ Lees DC Marsden B Halliwell 1998 Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species J Neurochem 71 2112 2122
65. JP Spencer M Whiteman P Jenner B Halliwell 2002 5-s-Cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neurons J Neurochem 81 122 129
66. MB Spina G Cohen 1989 Dopamine turnover and glutathione oxidation: implications for Parkinson disease Proc Natl Acad Sci USA 86 1398 1400
67. MB Stern 2004 Dopamine agonists modify the course of Parkinson disease Arch Neurol 61 1969 1971
68. H Takashima M Tsujihata M Kishikawa WJ Freed 1999 Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors Exp Neurol 159 98 104
69. MJ Tsai EH Lee 1996 Characterization of L-DOPA transport in cultured rat and mouse astrocytes J Neurosci Res 43 490 495
70. P Weingarten J Bermak QY Zhou 2001 Evidence for non-oxidative dopamine cytotoxicity: potent activation of NF-kappa B and lack of protection by anti-oxidants J Neurochem 76 1794 1804
71. AL Whone RL Watts AJ Stoessl M Davis S Reske C Nahmias AE Lang O Rascol MJ Ribeiro P Remy WH Poewe RA Hauser DJ Brooks 2003 Slower progression of Parkinson's disease with ropinirole versus levodopa: the REAL-PET study Ann Neurol 54 93 101
72. J Zhou HF Bradford GM Stern 1996 Induction of dopaminergic neurotransmitter phenotype in rat embryonic cerebrocortex by the synergistic action of neurotrophins and dopamine Eur J Neurosci 8 2328 2339